IDT and Elegen partner to launch an early access program offering long, clonal gene synthesis and high-complexity genes up to 15 kb.

Integrated DNA Technologies and Elegen are uniting to revolutionize the long DNA synthesis market, marking the launch of ...

The Series B funds will support the launch of a Phase I/II clinical trial for AIR-001 to advance its RNA editing pipeline.

Korro Bio's OPERA platform offers precise RNA editing for genetic diseases like Alpha-1 antitrypsin deficiency. Learn more on ...

Wave Life Sciences’ Phase II open-label trial investigating its disease-modifying drug for boys living with Duchenne Muscular ...

The “warm” data in the middle, such as your old photos, can take a few seconds to retrieve. Most data is cold, and a lot of ...

AIRNA, a transatlantic RNA editing biotech, is prepping to launch its lead asset into clinical trials with fuel from a $155 ...

Discover how RNA therapeutics are reshaping medicine, offering new treatments for previously undruggable targets.

Prudential Financial Inc. lessened its stake in shares of Twist Bioscience Co. (NASDAQ:TWST – Free Report) by 18.1% in the ...

We are excited to welcome Dr. Vincent, whose extensive drug development experience and expertise in translating groundbreaking science into therapies will be instrumental in leading our scientific ...